Loading Events

« All Events

  • This event has passed.

WEBINAR – Deprescribing Psychotropics

Tue 29th April @ 7:00 pm

The overuse of antidepressants and psychiatric medications is a growing concern for healthcare and regulatory bodies, including the NDIS Commission and the Australian Commission on Safety and Quality in Health Care. Both the Disability and Aged Care Royal Commissions have called for efforts to reduce this overuse.

Stopping these medications safely has been neglected in psychiatric teaching, leading to significant harm from severe and prolonged withdrawal effects. The Maudsley Deprescribing Guidelines aim to address this gap.

Withdrawal effects are more common and severe than previously recognized, with some people experiencing debilitating protracted withdrawal syndromes. These effects can be mistaken for a relapse or new condition, highlighting the need for better recognition and distinction.

Advances in the science of stopping antidepressants have led to updated UK guidelines on gradual, hyperbolic tapering.

DATE:
Tue 29th April


TIME:
7:00 pm - 8:30 pm


RACGP CPD POINTS:
This is an RACGP-approved CPD activity under the RACGP CPD Program - Activity Number: 1228123 | Activity Type EA 1.5

SPEAKERS:

Dr. Mark Horowitz MBBS PhD is a Clinical Research Fellow in Psychiatry with the NHS in England and a Visiting Lecturer in Psychopharmacology at King’s College London. He holds a PhD in the neurobiology of depression and antidepressant action.

Dr. Horowitz is the lead author of the Maudsley Deprescribing Guidelines and co-authored the Royal College of Psychiatrists’ guidance on ‘Stopping Antidepressants’. His work has informed NICE guidelines on safe tapering of psychiatric medications. He has published papers in top journals and is an Associate Editor of Therapeutic Advances in Psychopharmacology. His personal experience with psychiatric medication withdrawal has greatly influenced his work.

TARGET AUDIENCE:

GPs, Nurses, Allied Health Professionals, Pharmacists, any prescribers or clinicians that have regular contact with people using psychotropic medications

 

LEARNING OUTCOMES:
  • Identify when, why and in whom to stop antidepressants and other psychiatric drugs
  • Describe the risks of stopping these medications too quickly
  • Distinguish between withdrawal effects from these drugs and relapse of an underlying condition
  • Apply the latest principles in safe tapering to stopping these drugs classes, adjusted to the individual patient
COST:
There is no cost for Practices and their staff within the SNHN region to attend this training


ENQUIRIES:

Judy or Robi, Education Coordinators – 9432 8250 or events@snhn.org.au.



REGISTER FOR WEBINAR:
Click here to register online


^ We will use this email as your preferred email for event communication purposes (e.g. registrations, associated materials, certificates). We will also use it for future SNHN communications unless you request otherwise.

To view our Event Invoicing, Payments and Refunds Policy please click here.